UBS AM’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-51,000
| Closed | -$4.97M | – | 2754 |
|
|
2015
Q1 | $4.97M | Buy |
51,000
+3,400
| +7% | +$332K | ﹤0.01% | 1048 |
|
|
2014
Q4 | $4.42M | Sell |
47,600
-100
| -0.2% | -$9.28K | ﹤0.01% | 1067 |
|
|
2014
Q3 | $3.28M | Sell |
47,700
-2,200
| -4% | -$151K | ﹤0.01% | 1138 |
|
|
2014
Q2 | $5.23M | Sell |
49,900
-4,809
| -9% | -$504K | 0.01% | 1025 |
|
|
2014
Q1 | $4.54M | Sell |
54,709
-5,791
| -10% | -$480K | ﹤0.01% | 1059 |
|
|
2013
Q4 | $3.92M | Sell |
60,500
-2,700
| -4% | -$175K | ﹤0.01% | 1067 |
|
|
2013
Q3 | $4M | Buy |
63,200
+6,900
| +12% | +$437K | ﹤0.01% | 1039 |
|
|
2013
Q2 | $2.37M | Buy |
+56,300
| New | +$2.37M | ﹤0.01% | 1158 |
|